Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Hormone Research in Paediatrics

Volumn 74, Issue 1, 2010, Pages 41-49

  Zimmermann, Anca ^a,f   Grigorescu Sido, Paula ^e   Alkhzouz, Camelia ^e   Patberg, Karen ^a   Bucerzan, Simona ^e   Schulze, Egbert ^d   Zimmermann, Tim ^b   Rossmann, Heidi ^c   Geiss, Hans Christian ^a   Lackner, Karl J ^c   Weber, Matthias M ^a  

^a Department of Endocrinology and Metabolic Diseases   (Germany)

^b Department of Gastroenterology ^*  (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Laboratory for Molecular Genetics   (Germany)

^e IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f 1st Clinic for Internal Medicine   (Germany)

Author keywords

21 Hydroxylase; Atherogenesis; Small dense low density lipoproteins

Indexed keywords

CARBOHYDRATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; PREDNISONE; STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CAUCASIAN; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE SUBSTITUTION; HUMAN; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PREDICTION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; SUBSTITUTION THERAPY;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CARBOHYDRATE METABOLISM; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; STATISTICS, NONPARAMETRIC; STEROID 21-HYDROXYLASE; TRIGLYCERIDES; YOUNG ADULT;

EID: 77954797792     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000313368     Document Type: Article

References (38)

1. Speiser PW, White PC: Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788.
2. New MI, Ghizzoni L: Congenital adrenal hyperplasia; in Lifschitz F (ed): Pediatric Endocrinology, ed 4. New York, Marcel Dekker, 2003, pp 175-178.
3. Merke DP, Bornstein SR: Congenital adrenal hyperplasia. Lancet 2005;365:2125-2136.
4. Volkl TM, Simm S, Beier C, Dorr HG: Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006; 117:e98-e105.
5. Stikkelbroeck NM, Oyen WJG, Van der Wilt GJ, Hermus MM, Otten BJ: Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003;88:1036-1042.
6. Charmandari E, Weise M, Bornstein S, Eisenhofer G, Keil MF, Chrousis GP, Merke DP: Children with classic congenital hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002;87: 2114-2120.
7. Riepe FG, Krone N, Kruger SN, Sweep FC, Lenders JW, Dotsch J, Monig H, Sippel WG, Partsch CJ: Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes 2006;114:105-110.
8. Roche E, Charmandari E, Dattani MT, Hindmarsh PC; Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol (Oxf) 2003;58:589-596.
9. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K, Thoren M: Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007;92: 110-116.
10. Paula FJ, Gouveia GM, Piccinato CE, Moreira AC, Foss MC: Androgen - related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia. Horm Metab Res 1994;26:552-556.
11. Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Feke- te C, Kuttenn F, Polak M, Touraine P: Long- term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2007;67:268-276.
12. Fleischman A, Paltiel H, Chow J, Ringelheim J, Gordon CM: Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 2007; 20:67-72.
13. Charmandari E, Chrousos GP: Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann NY Acad Sci 2006;1083: 37-53.
14. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM: A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 1981;22:339-358.
15. Nigon F, Lesnik P, Rouis M, Chapman MJ: Discrete subspecies of human low density lipoproteins are heterogenous in their interaction with the cellular LDL receptor. J Lipid Res1991;32:1741-1753.
16. Austin MA, Breslow CH, Hennekens CH, Buring JE, Willet WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;260:1917-1921.
17. Lamarche B, Tchernof A, Moorjani S, Chantin B, Dagenais GR, Lupien PJ, Despres JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997;95: 69-75.
18. Vakkilainen J, Steiner G, Ansquer JC, Aaubin F, Rattier S, Foucher C, Hamsten A, Taskinen MR: Relationships between LDL lipoprotein particle size, plasma lipoproteins and progression of coronary artery disease. Circulation 2003;107:1733-1737.
19. Krone N, Braun A, Roscher AA, Knorr D, Schwartz HP: Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well- defined patients from Southern Germany. J Clin Endocrinol Metab 2000;85:1059-1065.
20. Grigorescu-Sido A, Weber MM, Grigorescu- Sido P, Clausmeyer S, Heinrich U, Schulze E: 21-Hydroxylase and 11β-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005;90:5769-5773.
21. Miller WL: The adrenal cortex; in Rudolph AM, Hofmann JIE (eds): Pediatrics. Nor- walk, Appleton & Lange, 1991, pp 15841613.
22. Reincken L, van Oost G: Longitudinale Korperentwicklung gesunder Kinder von 0-18 Jahren. Korperlange, -hohe, Korpergewicht und Wachstumsgeschwindigkeit. Klin Padiatr 1992;204:129-133.
23. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Stanford, Stanford University Press, 1959.
24. Geiss HC, Bremer S, Barrett PHR, Otto C, Parhofer KG: In vivo metabolism of LDL subfractions in patients with homozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis. J Lipid Res 2004;45:1459-1467.
25. Genuth S, Alberti KG, Bennett P, et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cells function from fasting plasma glucose and insulin concentration in men. Diabetologia 1985;28:412-419.
27. Monzillo LU, Osama H: Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003;61:397-412.
28. Sartorato P, Zulian E, Benedini S, Mariniello B, Schiavi F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C: Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21- hydroxylase deficiency. J Clin Endocrinol Metab 2007;92:1015-1018.
29. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
30. Fernandez-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278301.
31. Daniels SR: Cardiovascular disease risk factors and atherosclerosis in children and adolescents. Curr Atheroscler Rep 2001;3:479-485.
32. Lyon CJ, Law RE, Hsueh WA: Minireview: adiposity, inflammation and atherogenesis. Endocrinology 2003; 144:2195-2200.
33. Calles-Escandon J, Cipolla M: Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001;22:36-52.
34. Livingstone C, Collison M: Sex steroids and insulin resistance. Clin Sci 2002; 102:151166.
35. Vitarius JA: The metabolic syndrome and cardiovascular disease. Mt Sinai J Med 2005; 72: 257-262.
36. Quyyumi A A: Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105: 32S-39S.
37. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endcr Rev 1997; 18:774-800.
38. Cole TJ, Freeman JV, Preece MA: Body mass index reference curves for the UK, 1990. Arch Dis Childh 1995;73:25-29.